AAAAAA
Results:
1-13
|
Results: 13
Authors:
Meredith, RF
Alvarez, RD
Partridge, EE
Khazaeli, MB
Lin, CY
Macey, DJ
Austin, JM
Kilgore, LC
Grizzle, WE
Schlom, J
LoBuglio, AF
Citation: Rf. Meredith et al., Intraperitoneal radioimmunochemotherapy of ovarian cancer: A phase I study, CANC BIO R, 16(4), 2001, pp. 305-315
Authors:
Chaudhuri, TR
Mountz, JM
Rogers, BE
Partridge, EE
Zinn, KR
Citation: Tr. Chaudhuri et al., Light-based imaging of green fluorescent protein-positive ovarian cancer xenografts during therapy, GYNECOL ONC, 82(3), 2001, pp. 581-589
Authors:
Rodriguez-Burford, C
Barnes, MN
Berry, W
Partridge, EE
Grizzle, WE
Citation: C. Rodriguez-burford et al., Immunohistochemical expression of molecular markers in an avian model: A potential model for preclinical evaluation of agents for ovarian cancer chemoprevention, GYNECOL ONC, 81(3), 2001, pp. 373-379
Authors:
Partridge, EE
Citation: Ee. Partridge, Differentiation between the sick and the dying: An ancient art forgotten in modern medicine, GYNECOL ONC, 79(1), 2000, pp. 1-3
Authors:
Straughn, JM
Robertson, MW
Partridge, EE
Citation: Jm. Straughn et al., A patient presenting with a pelvic mass, elevated CA-125, and fever, GYNECOL ONC, 77(3), 2000, pp. 471-472
Authors:
Bland, KI
Menck, HR
Partridge, EE
Fremgen, A
Scott-Conner, CEH
Hundahl, S
Winchester, DP
Morrow, M
Citation: Ki. Bland et al., The National Cancer Data Base: What does it mean to the community surgeon?, J SURG ONC, 73(4), 2000, pp. 189-191
Authors:
Partridge, EE
Citation: Ee. Partridge, NCCN practice guidelines for cervical cancer screening, ONCOLOGY-NY, 13(11A), 1999, pp. 550-574
Authors:
Barnes, MN
Roland, PY
Straughn, M
Kilgore, LC
Alvarez, RD
Partridge, EE
Citation: Mn. Barnes et al., A comparison of treatment strategies for endometrial adenocarcinoma: Analysis of financial impact, GYNECOL ONC, 74(3), 1999, pp. 443-447
Authors:
Bajaj, PK
Barnes, MN
Robertson, MW
Shah, P
Austin, JM
Partridge, EE
Austin, JM
Citation: Pk. Bajaj et al., Surgical management of endometrial adenocarcinoma using laparoscopically assisted staging and treatment, SOUTH MED J, 92(12), 1999, pp. 1174-1177
Authors:
Yarbro, JW
Page, DL
Fielding, LP
Partridge, EE
Murphy, GP
Citation: Jw. Yarbro et al., American Joint Committee on Cancer Prognostic Factors Consensus Conference, CANCER, 86(11), 1999, pp. 2436-2446
Authors:
Partridge, EE
Barnes, MN
Citation: Ee. Partridge et Mn. Barnes, Epithelial ovarian cancer: Prevention, diagnosis, and treatment, CA-A CANC J, 49(5), 1999, pp. 297-320
Authors:
Partridge, EE
Citation: Ee. Partridge, Ovarian cancer: Considerations for the general surgeon, CANCER SURGERY FOR THE GENERAL SURGEON, 1999, pp. 297-308
Authors:
Naumann, RW
Alvarez, RD
Omura, GA
Segars, E
Kilgore, LC
Partridge, EE
Citation: Rw. Naumann et al., A phase I study of paclitaxel, doxorubicin, and cisplatin in patients withpreviously untreated epithelial ovarian cancer, GYNECOL ONC, 71(3), 1998, pp. 450-453
Risultati:
1-13
|